Drugs / Liposomal doxorubicine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00721747 | Jan 2008 → Jan 2011 | breast cancer | Grupo Oncológico Gallego | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Liposomal doxorubicine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00721747 ↗ |
| Route | Intravenous | “Liposomal doxorubicine 60mg/m2/iv” NCT00721747 ↗ |